Molecular Devices and HeartBeat.bio announce collaboration to automate... Posted By: Anonymous | Posted On: Sep 12,2022 11:00 am | View: 40 Molecular Devices, LLC., a leading provider of high-performance life science solutions, and HeartBeat.bio AG, a biotech company developing cardiac organoids (Cardioids) for drug discovery, enter into... read more ...
European digital health company launches new initiative to support... Posted By: Anonymous | Posted On: Sep 11,2022 11:00 am | View: 67 The potential of digital health is enormous, but there are challenges to overcome before we see widespread adoption in clinical settings. To support cardiac researchers and advance the adoption of... read more ...
WizeCare Announces Know-how and Research Agreement with Mayo Clinic Posted By: Anonymous | Posted On: Sep 07,2022 23:00 pm | View: 88 The collaboration aims to develop a home-based cardiac rehabilitation program to set a new standard of care by harnessing Mayo Clinic's know-how with WizeCare’s groundbreaking AI-driven technology... read more ...
Congestive Heart Failure Patients May Be Eligible for Treatment that... Posted By: Anonymous | Posted On: Aug 18,2022 23:00 pm | View: 87 Patients diagnosed with moderate aortic stenosis and congestive heart failure may qualify to participate in a national clinical trial that includes Memorial Cardiac and Vascular Institute and will... read more ...
Disclaimer: Issuers of the submissions/postings are solely responsible for the content of their submissions. Doctorsoutlook.com can't be held liable for the contents of these submissions. In case any submission damages your benefits or violate your rights in any way, please contact us and we'll remove it immediately.
